These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9828916)

  • 1. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR; Andrew R; MacLeod KM; Padfield PL
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.
    Toogood AA; Taylor NF; Shalet SM; Monson JP
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1727-30. PubMed ID: 10770221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M; Shackleton CH; Mantero F; Stewart PM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
    Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate.
    Beentjes JA; Kerstens MN; Dullaart RP
    Scand J Clin Lab Invest; 2001 Jul; 61(4):277-86. PubMed ID: 11465341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
    Best R; Walker BR
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):231-6. PubMed ID: 9302399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects.
    Weaver JU; Taylor NF; Monson JP; Wood PJ; Kelly WF
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):13-20. PubMed ID: 9797842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.
    Walker BR; Campbell JC; Fraser R; Stewart PM; Edwards CR
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):483-92. PubMed ID: 1337504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.
    Sigurjonsdottir HA; Andrew R; Stimson RH; Johannsson G; Walker BR
    Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig.
    Quinkler M; Troeger H; Eigendorff E; Maser-Gluth C; Stiglic A; Oelkers W; Bähr V; Diederich S
    J Endocrinol; 2003 Feb; 176(2):185-92. PubMed ID: 12553867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
    Finken MJ; Andrews RC; Andrew R; Walker BR
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
    J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
    Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP
    Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
    Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11beta-hydroxysteroid dehydrogenase and corticosteroid action in lyon hypertensive rats.
    Lloyd-MacGilp SA; Nelson SM; Florin M; Lo M; McKinnell J; Sassard J; Kenyon CJ
    Hypertension; 1999 Nov; 34(5):1123-8. PubMed ID: 10567193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
    Walker BR; Stewart PM; Shackleton CH; Padfield PL; Edwards CR
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.